GWPHARM
DEAD

Serial Number

79154002

Owner

GW Pharma Limited

Attorney

Michelle L. Visser

Filing Date

Jun 5, 2014

Add to watchlist:

No watchlists yet
View on USPTO

GWPHARM Trademark

Serial Number: 79154002

GWPHARM is a trademark filed by GW Pharma Limited on June 5, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

June 5, 2014

Registration Date

Not Registered

Published for Opposition

February 17, 2015

Goods & Services

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 21, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Dec 21, 2024 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 28, 2016 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2016 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 13, 2016 FICR
ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Oct 13, 2015 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Oct 13, 2015 ABN4
OPPOSITION TERMINATED NO. 999999
Oct 13, 2015 OP.T
OPPOSITION SUSTAINED NO. 999999
Oct 13, 2015 OP.S
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 19, 2015 ADCH
REFUSAL PROCESSED BY IB
Apr 24, 2015 RFNP
OPPOSITION INSTITUTED NO. 999999
Mar 23, 2015 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 20, 2015 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Mar 20, 2015 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Mar 19, 2015 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2015 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 28, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 28, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 14, 2015 PREV
ASSIGNED TO LIE
Jan 14, 2015 ALIE
ASSIGNED TO LIE
Jan 12, 2015 ALIE
ASSIGNED TO LIE
Jan 12, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2014 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 25, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 25, 2014 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2014 TROA
REFUSAL PROCESSED BY IB
Nov 21, 2014 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 8, 2014 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 6, 2014 RFCS
REFUSAL PROCESSED BY MPU
Nov 6, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2014 RFCR
NON-FINAL ACTION WRITTEN
Nov 4, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 30, 2014 REPR